Yann-Lii Leu Selected Research

Yann-Lii Leu Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 04/2007
15	Inflammation (Inflammations) 02/2022 - 11/2006
9	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 06/2009
5	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2015
4	Liver Neoplasms (Liver Cancer) 09/2021 - 12/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 02/2020
4	Infections 01/2017 - 01/2007
3	Hyperplasia 02/2024 - 01/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 07/2015
3	Body Weight (Weight, Body) 02/2022 - 12/2019
3	Insulin Resistance 01/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
3	Obesity 01/2021 - 01/2019
3	Atherosclerosis 03/2020 - 10/2011
3	Fibrosis (Cirrhosis) 01/2019 - 02/2012
2	Breast Neoplasms (Breast Cancer) 09/2021 - 04/2007
2	Squamous Cell Carcinoma of Head and Neck 09/2021 - 01/2019
2	Hypertension (High Blood Pressure) 08/2015 - 06/2011
2	Skin Diseases (Skin Disease) 01/2013 - 02/2012
1	Necrosis 02/2024
1	Dysbiosis 02/2022
1	Colitis-Associated Neoplasms 02/2022
1	Carcinogenesis 02/2022
1	Colitis 02/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Dermatitis 10/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Atherosclerotic Plaque (Atheroma) 03/2020
1	Endotoxemia 12/2019
1	Fatty Liver 12/2019

Drug/Important Bio-Agent (IBA)

6	Indigo Carmine (Indigo Blue)IBA 12/2019 - 06/2009
5	corylinIBA 11/2023 - 01/2018
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2012
4	hydroxygenkwaninIBA 09/2021 - 12/2019
4	viscolinIBA 01/2016 - 11/2006
3	Becaplermin (PDGF-BB)FDA Link 02/2024 - 01/2016
3	Imiquimod (Aldara)FDA LinkGeneric 10/2021 - 11/2018
3	FlavonoidsIBA 01/2021 - 11/2017
3	LipidsIBA 03/2020 - 02/2013
2	CytokinesIBA 02/2024 - 11/2017
2	AntioxidantsIBA 01/2022 - 07/2009
2	Insulin (Novolin)FDA Link 01/2022 - 12/2019
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2021 - 12/2015
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2020
2	ApolipoproteinsIBA 03/2020 - 02/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 01/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2020
2	NF-kappa B (NF-kB)IBA 02/2019 - 01/2012
2	growth arrest specific transcript 5IBA 01/2019 - 01/2018
2	Long Noncoding RNAIBA 01/2019 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2007
2	Qingdai compoundIBA 03/2012 - 08/2009
1	ApelinIBA 02/2024
1	Platelet-Derived Growth FactorIBA 02/2024
1	isoxanthohumolIBA 02/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2023
1	Phosphotransferases (Kinase)IBA 05/2022
1	Dextrans (Dextran)FDA Link 02/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2022
1	propolin GIBA 01/2022
1	Propolis (Bee Bread)IBA 01/2022
1	Glycogen Synthase KinasesIBA 01/2022
1	VimentinIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Endothelial Growth FactorsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	imperatorinIBA 10/2021
1	Furocoumarins (Furanocoumarins)IBA 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	palbociclibIBA 09/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2021
1	bavachininIBA 08/2021
1	flavanoneIBA 08/2021
1	QuercetinIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	brigatinibIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 03/2020
1	magnololIBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2019
1	LigandsIBA 12/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Interleukin-22 (IL-22)IBA 12/2019

Therapy/Procedure

6	Therapeutics 10/2021 - 01/2015
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 01/2011
2	Radiotherapy 09/2021 - 10/2019
2	Drug Therapy (Chemotherapy) 09/2021 - 10/2019
1	Adjuvant Chemotherapy 09/2021
1	Chemoprevention 08/2021